Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Ear, Nose and Throat Disorders
Published in: BMC Ear, Nose and Throat Disorders 1/2015

Open Access 01-12-2015 | Study protocol

CINGLE-trial: cochlear implantation for siNGLE-sided deafness, a randomised controlled trial and economic evaluation

Authors: Jeroen PM Peters, Alice van Zon, Adriana L Smit, Gijsbert A van Zanten, G Ardine de Wit, Inge Stegeman, Wilko Grolman

Published in: BMC Ear, Nose and Throat Disorders | Issue 1/2015

Login to get access

Abstract

Background

Individuals with single-sided deafness (SSD) have problems with speech perception in noise, localisation of sounds and with communication and social interaction in their daily life. Current treatment modalities (Contralateral Routing of Sound systems [CROS] and Bone Conduction Devices [BCD]) do not restore binaural hearing. Based on low level of evidence studies, CROS and BCD do not improve speech perception in noise or sound localisation. In contrast, cochlear implantation (CI) may overcome the limitations of CROS and BCD, as binaural input can be restored. Promising results have previously been achieved on speech perception in noise, sound localisation, tinnitus and quality of life.

Methods and design

A single-center Randomised Controlled Trial (RCT) was designed to compare all treatment strategies for SSD. One hundred and twenty adult single-sided deaf patients (duration of deafness >3 months and maximum 10 years; pure tone average at 0.5, 1, 2, 4 kHz, deaf ear: threshold equal to or more than 70 dB, better ear: threshold of maximum 30 dB) will be included in this trial and randomised to CI, ‘first BCD, then CROS’ or ‘first CROS, then BCD’-groups. After the trial period, patients in the two latter groups may choose with which treatment option they continue. Outcomes of interest are speech perception in noise, sound localization, tinnitus and quality of life. These outcomes will be measured during a baseline visit and at follow up visits, which will take place at 6, 12, 18, 24, 36, 48 and 60 months after onset of treatment. Furthermore, an economic evaluation will be performed and adverse events will be monitored.

Discussion

This RCT allows for a comparison between the two current treatment modalities for single-sided deafness and a new promising treatment strategy, CI, on a range of health outcomes: speech perception in noise, sound localization, tinnitus and quality of life. Additionally, we will be able to answer the question if the additional costs of CI are justified by increased benefits, when compared to current treatment strategies. This study will inform health policy makers with regard to reimbursement of CI.

Trial registration

Netherlands Trial Register (www.​trialregister.​nl): NTR4580.
Literature
1.
2.
Middlebrooks JC, Green DM. Sound localization by human listeners. Ann Rev Psychol. 1991;42:135–59.CrossRef
3.
Dunn CC, Tyler RS, Oakley S, Gantz BJ, Noble W. Comparison of speech recognition and localization performance in bilateral and unilateral cochlear implant users matched on duration of deafness and age at implantation. Ear Hear. 2008;29:325–59.CrossRef
4.
Van Wanrooij MM, Van Opstal AJ. Contribution of head shadow and pinna cues to chronic monaural sound localization. J Neurosci. 2004;24(17):4163–71.CrossRefPubMed
5.
Wie OB, Pripp AH, Tvete O. Unilateral deafness in adults: effects on communication and social interaction. Ann Otol Rhinol Laryngol. 2010;119(11):772–81.PubMed
6.
Peters JPM, Smit AL, Stegeman I, Grolman W. Review: Bone conduction devices and contralateral routing of sound systems in single-sided deafness. Laryngoscope. 2015;125:218–26.CrossRefPubMed
7.
Kamal SM, Robinson AD, Diaz RC. Cochlear implantation in single-sided deafness for enhancement of sound localization and speech perception. Curr Opin Otolaryngol Head Neck Surg. 2012;20:393–7.CrossRefPubMed
8.
Vlastarakos PV, Nazos K, Tavoulari EF, Nikolopoulos TP. Cochlear implantation for single-sided deafness: the outcomes. An evidence based approach. Eur Arch Otorhinolaryngol. 2014;271(8):2119–26.CrossRefPubMed
9.
Blasco MA, Redleaf MI. Cochlear implantation in unilateral sudden deafness improves tinnitus and speech comprehension: meta-analysis and systematic review. Otol Neurotol. 2014;35(8):1426–32.CrossRefPubMed
10.
Arts RA, George EL, Stokroos RJ, Vermeire K. Review: cochlear implants as a treatment of tinnitus in single-sided deafness. Curr Opin Otolaryngol Head Neck Surg. 2012;20(5):398–403.CrossRefPubMed
11.
Van Zon A, Peters JPM, Smit AL, Stegeman I, Grolman W. Cochlear implantation for patients with single-sided deafness or asymmetrical hearing loss: a systematic review of the evidence. Otol Neurotol. 2015;36:209–19.CrossRefPubMed
12.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7.CrossRefPubMed
13.
Holube I, Fredelake S, Vlaming M, Kollmeier B. Development and analysis of an International Speech Test Signal (ISTS). Int J Audiol. 2010;49(12):891–903.CrossRefPubMed
14.
Desmet J, Bouzegta R, Hofkens A, De Backer A, Lambrechts P, Wouters K, et al. Clinical need for a Baha trial in patients with single-sided sensorineural deafness. Analysis of a Baha database of 196 patients. Eur Arch Otolaryngol. 2012;269:799–605.CrossRef
15.
Smulders YE, Rinia AB, Pourier VEC, Van Zon A, Van Zanten GA, Stegeman I, et al. Validation of the U-STARR with the AB-York crescent of sound, a new instrument to evaluate speech intelligibility in noise and spatial hearing skills. Audiol Neurotol Extra. 2015;5:1–10.CrossRef
16.
Kitterick PT, Lovett RE, Goman AM, Summerfield AQ. The AB-York crescent of sound: an apparatus for assessing spatial-listening skills in children and adults. Cochlear Implants Int. 2011;12(3):164–9.CrossRefPubMed
17.
Versfeld NJ, Daalder L, Festen JM, Houtgast T. Method for the selection of sentence materials for efficient measurement of the speech reception threshold. J Acoust Soc Am. 2000;107:1671–84.CrossRefPubMed
18.
Newman CW, Jacobson GP, Spitzer JB. Development of the tinnitus handicap inventory. Arch Otolaryngol Head Neck Surg. 1996;122:143–8.CrossRefPubMed
19.
Hallam RS, Jakes SC, Hinchcliffe R. Cognitive variables in tinnitus annoyance. Br J Clin Psychol. 1988;27(pt3):213–22.CrossRefPubMed
20.
Goebel G, Hiller W. The tinnitus questionnaire. A standard instrument for grading the degree of tinnitus. Results of a multicenter study with the tinnitus questionnaire. HNO. 1994;42(3):166–72.PubMed
21.
Meeus O, Blaivie C, Van de Heyning P. Validation of the Dutch and the French version of the Tinnitus Questionnaire. B-ENT. 2007;3 Suppl 7:11–7.PubMed
22.
Gatehouse S, Noble W. The speech, spatial and qualities of hearing scale (SSQ). Inter J Audio. 2004;43:85–99.CrossRef
23.
Cox RM, Alexander GC. The abbreviated profile for hearing aid benefit. Ear Hear. 1998;16:176–86.CrossRef
24.
Robinson K, Gatehouse S, Browning GG. Measuring patient benefit from otorhinolaryngological surgery and therapy. Ann Otol Rhinol Laryngol. 1996;105:415–22.CrossRefPubMed
25.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.CrossRefPubMed
26.
The EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.CrossRef
27.
Lamers LM, Stalmeier PFM, McDonnell J, KRabbe PFM, Van Busschbach JJ. Kwaliteit van leven meten in economische evaluaties: het Nederlands EQ-5D-tarief. Ned Tijdsch v Geneesk. 2005;149:1574–8.
28.
Feeny D, Furlong W, Torrance G. Multiple attributes and single attribute utility functions for Health Utility Index Mark 3 system. Med Care. 2002;40:113–28.CrossRefPubMed
29.
Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. College voor zorgverzekeringen. Geactualiseerde versie 2010. Available via www.​zorginstituutned​erland.​nl, accessed November 10, 2014.
30.
Schulz KF, Altman DG, Moher D for the CONSORT group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.CrossRefPubMedPubMedCentral
31.
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel groups randomised trials. BMJ. 2010;340:c869.CrossRefPubMedPubMedCentral
Metadata
Title
CINGLE-trial: cochlear implantation for siNGLE-sided deafness, a randomised controlled trial and economic evaluation
Authors
Jeroen PM Peters
Alice van Zon
Adriana L Smit
Gijsbert A van Zanten
G Ardine de Wit
Inge Stegeman
Wilko Grolman
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Ear, Nose and Throat Disorders / Issue 1/2015
Electronic ISSN: 1472-6815
DOI
https://doi.org/10.1186/s12901-015-0016-y

Other articles of this Issue 1/2015

BMC Ear, Nose and Throat Disorders 1/2015 Go to the issue

Research article

Discriminant validity and test re-test reproducibility of a gait assessment in patients with vestibular dysfunction

Study protocol

A study protocol for a cluster randomised trial for the prevention of chronic suppurative otitis media in children in Jumla, Nepal

Reviewer acknowledgement

BMC Ear, Nose and Throat Disorders reviewer acknowledgement 2014

Research article

Laryngopharyngeal reflux disease in the Greek general population, prevalence and risk factors

Research article

Comparative bactericidal activity of four fluoroquinolones against Pseudomonas aeruginosa isolated from chronic suppurative otitis media

Case report

Light cupula of the horizontal semicircular canal occurring alternately on both sides: a case report